Lutgarde Lynen, Ph.D. - Publications

Affiliations: 
2009 Universiteit Antwerpen (Belgium) 
Area:
Epidemiology

106 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Gils T, Kamele M, Madonsela T, Bosman S, Ngubane T, Joseph P, Reither K, Bresser M, Vlieghe E, Decroo T, Ayakaka I, Lynen L, Van Heerden A. Implementation of the advanced HIV disease care package with point-of-care CD4 testing during tuberculosis case finding: A mixed-methods evaluation. Plos One. 18: e0296197. PMID 38134020 DOI: 10.1371/journal.pone.0296197  0.352
2023 Mesic A, Decroo T, Florence E, Ritmeijer K, van Olmen J, Lynen L. Systematic review on cumulative HIV viraemia among people living with HIV receiving antiretroviral treatment and its association with mortality and morbidity. International Health. PMID 37823452 DOI: 10.1093/inthealth/ihad093  0.312
2022 Mesic A, Homan T, Lenglet A, Thit P, Mar HT, Sabai SM, Thandar MP, Thwe TT, Kyaw AA, Decroo T, Spina A, Ariti C, Ritmeijer K, Van Olmen J, Oo HN, ... Lynen L, et al. Advanced HIV disease and associated attrition after re-engagement in HIV care in Myanmar from 2003 to 2019: a retrospective cohort study. International Health. PMID 36318805 DOI: 10.1093/inthealth/ihac069  0.314
2022 Gils T, Lynen L, Muhairwe J, Mashaete K, Lejone TI, Joseph P, Ngubane T, Keter AK, Reither K, van Heerden A. Feasibility of implementing the advanced HIV disease care package as part of community-based HIV/TB activities: a mixed-methods study protocol. Bmj Open. 12: e057291. PMID 35131835 DOI: 10.1136/bmjopen-2021-057291  0.328
2021 Mesic A, Spina A, Mar HT, Thit P, Decroo T, Lenglet A, Thandar MP, Thwe TT, Kyaw AA, Homan T, Sangma M, Kremer R, Grieg J, Piriou E, Ritmeijer K, ... ... Lynen L, et al. Predictors of virological failure among people living with HIV receiving first line antiretroviral treatment in Myanmar: retrospective cohort analysis. Aids Research and Therapy. 18: 16. PMID 33882962 DOI: 10.1186/s12981-021-00336-0  0.347
2021 Gonzaga LDM, Gils T, Decroo T, Jacobs BKM, Lynen L. Case Report: Therapeutic Threshold for Rifampicin-Resistant Tuberculosis: A Case Report from Maputo, Mozambique. The American Journal of Tropical Medicine and Hygiene. PMID 33556043 DOI: 10.4269/ajtmh.20-0959  0.308
2020 Makurumidze R, Buyze J, Decroo T, Lynen L, de Rooij M, Mataranyika T, Sithole N, Takarinda KC, Apollo T, Hakim J, Van Damme W, Rusakaniko S. Patient-mix, programmatic characteristics, retention and predictors of attrition among patients starting antiretroviral therapy (ART) before and after the implementation of HIV "Treat All" in Zimbabwe. Plos One. 15: e0240865. PMID 33075094 DOI: 10.1371/journal.pone.0240865  0.345
2020 Ndambuki J, Nzomo J, Muregi L, Mutuku C, Makokha F, Nthusi J, Ambale C, Lynen L, Decroo T. Comparison of first-line tuberculosis treatment outcomes between previously treated and new patients: a retrospective study in Machakos subcounty, Kenya. International Health. PMID 32860045 DOI: 10.1093/Inthealth/Ihaa051  0.364
2020 Makurumidze R, Decroo T, Lynen L, Chinwadzimba ZK, Van Damme W, Hakim J, Rusakaniko S. District-level strategies to control the HIV epidemic in Zimbabwe: a practical example of precision public health. Bmc Research Notes. 13: 393. PMID 32847619 DOI: 10.1186/S13104-020-05234-8  0.418
2020 Mesic A, Khan WH, Lenglet A, Lynen L, Ishaq S, Phyu EHH, Mar HT, Oraegbu A, Seddiq MK, Amirzada HK, Fernhout J, Kamau C, Ariti C, Gomez D, Decroo T. Translating drug resistant tuberculosis treatment guidelines to reality in war-torn Kandahar, Afghanistan: A retrospective cohort study. Plos One. 15: e0237787. PMID 32822375 DOI: 10.1371/Journal.Pone.0237787  0.366
2020 Hassane-Harouna S, Cherif GF, Ortuno-Gutierrez N, Cisse D, Camara LM, Diallo BD, Camara S, Bangoura AM, Lynen L, Decroo T. Better programmatic outcome with the shorter regimen for the treatment of multidrug-resistant tuberculosis (MDR-TB) in Guinea: A retrospective cohort study. Plos One. 15: e0237355. PMID 32776969 DOI: 10.1371/Journal.Pone.0237355  0.334
2020 Souleymane MB, Piubello A, Lawan IM, Hassane-Harouna S, Assao-Neino MM, Soumana A, Hamidou-Harouna Z, Gagara-Issoufou A, Ortuño-Gutiérrez N, Roggi A, Schwoebel V, Mamadou S, Lynen L, De Jong B, Van Deun A, et al. High rifampicin-resistant TB cure rates and prevention of severe ototoxicity after replacing the injectable by linezolid in early stage of hearing loss. The European Respiratory Journal. PMID 32703777 DOI: 10.1183/13993003.02250-2020  0.364
2020 Maug AKJ, Hossain MA, Gumusboga M, Decroo T, Mulders W, Braet S, Buyze J, Arango D, Schurmans C, Herssens N, Demeulenaere T, Lynen L, de Jong BC, Van Deun A. First-line tuberculosis treatment with double-dose rifampicin is well tolerated. The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease. 24: 499-505. PMID 32398199 DOI: 10.5588/Ijtld.19.0063  0.304
2020 Buyze J, Weggheleire A, van Griensven J, Lynen L. Comparison of predictive models for hepatitis C co-infection among HIV patients in Cambodia. Bmc Infectious Diseases. 20: 209. PMID 32164581 DOI: 10.1186/S12879-020-4909-Z  0.398
2020 Decroo T, de Jong BC, Piubello A, Souleymane MB, Lynen L, Van Deun A. High-dose First-line Treatment Regimen for Recurrent Rifampicin-susceptible Tuberculosis. American Journal of Respiratory and Critical Care Medicine. PMID 32130864 DOI: 10.1164/Rccm.202001-0201Le  0.313
2020 Decroo T, de Jong BC, Piubello A, Lynen L, Van Deun A. Tuberculosis treatment: one-shot approach or cascade of regimens? The Lancet. Respiratory Medicine. 8: e4-e5. PMID 32035067 DOI: 10.1016/S2213-2600(19)30473-4  0.324
2020 Makurumidze R, Mutasa-Apollo T, Decroo T, Choto RC, Takarinda KC, Dzangare J, Lynen L, Van Damme W, Hakim J, Magure T, Mugurungi O, Rusakaniko S. Retention and predictors of attrition among patients who started antiretroviral therapy in Zimbabwe's national antiretroviral therapy programme between 2012 and 2015. Plos One. 15: e0222309. PMID 31910445 DOI: 10.1371/Journal.Pone.0222309  0.328
2019 Stek C, Allwood B, Du Bruyn E, Buyze J, Schutz C, Thienemann F, Lombard A, Wilkinson RJ, Meintjes G, Lynen L. The effect of HIV-associated tuberculosis, tuberculosis-IRIS, and prednisone on lung function. The European Respiratory Journal. PMID 31862762 DOI: 10.1183/13993003.01692-2019  0.426
2019 Choun K, Decroo T, Mao TE, Lorent N, Gerstel L, Creswell J, Codlin AJ, Lynen L, Thai S. Performance of algorithms for tuberculosis active case finding in underserved high-prevalence settings in Cambodia: a cross-sectional study. Global Health Action. 12: 1646024. PMID 31500551 DOI: 10.1080/16549716.2019.1646024  0.315
2019 Yonga P, Kalya S, Lynen L, Decroo T. Temporary disengagement and re-engagement in human immunodeficiency virus care in a rural county serving pastoralist communities in Kenya: a retrospective cohort study. International Health. PMID 31227824 DOI: 10.1093/Inthealth/Ihz049  0.315
2019 Mollel E, Lekule I, Lynen L, Decroo T. Effect of reliance on Xpert MTB/RIF on time to treatment and multidrug-resistant tuberculosis treatment outcomes in Tanzania: a retrospective cohort study. International Health. PMID 30806660 DOI: 10.1093/Inthealth/Ihz005  0.36
2019 Yonga PO, Kalya SK, Lynen L, Decroo T. 1319. Events of Disengagement from HIV care and Subsequent Reengagement in a Kenyan Pastoralist Community: Frequency, Determinants, and Patient Views Open Forum Infectious Diseases. 6. DOI: 10.1093/Ofid/Ofz360.1182  0.371
2018 Meintjes G, Stek C, Blumenthal L, Thienemann F, Schutz C, Buyze J, Ravinetto R, van Loen H, Nair A, Jackson A, Colebunders R, Maartens G, Wilkinson RJ, Lynen L. Prednisone for the Prevention of Paradoxical Tuberculosis-Associated IRIS. The New England Journal of Medicine. 379: 1915-1925. PMID 30428290 DOI: 10.1056/Nejmoa1800762  0.444
2018 Weggheleire AD, Buyze J, An S, Thai S, Griensven Jv, Francque S, Lynen L. Development of a clinical prediction score for targeted hepatitis C screening in a low-risk HIV cohort in Cambodia Journal of Hepatology. 68. DOI: 10.1016/S0168-8278(18)30567-1  0.366
2017 Decroo T, Van Deun A, Lynen L. Comment on: Effects of isoniazid resistance on TB treatment outcomes under programmatic conditions in a high-TB and -HIV setting: a prospective multicentre study. The Journal of Antimicrobial Chemotherapy. PMID 29293989 DOI: 10.1093/Jac/Dkx497  0.425
2017 Lay P, An S, Soeung S, Srey PS, Thai S, Lynen L, Griensven JV. Ten year experience with antiretroviral treatment in Cambodia: Trends in patient characteristics and treatment outcomes. Plos One. 12: e0185348. PMID 29136011 DOI: 10.1371/Journal.Pone.0185348  0.383
2017 Decroo T, Henríquez-Trujillo AR, De Weggheleire A, Lynen L. Rational use of Xpert testing in patients with presumptive TB: clinicians should be encouraged to use the test-treat threshold. Bmc Infectious Diseases. 17: 674. PMID 29020943 DOI: 10.1186/S12879-017-2798-6  0.412
2017 De Weggheleire A, An S, De Baetselier I, Soeung P, Keath H, So V, Ros S, Teav S, Smekens B, Buyze J, Florence E, van Griensven J, Thai S, Francque S, Lynen L. A cross-sectional study of hepatitis C among people living with HIV in Cambodia: Prevalence, risk factors, and potential for targeted screening. Plos One. 12: e0183530. PMID 28832660 DOI: 10.1371/Journal.Pone.0183530  0.302
2017 Abongomera C, Ritmeijer K, Vogt F, Buyze J, Mekonnen Z, Admassu H, Colebunders R, Mohammed R, Lynen L, Diro E, van Griensven J. Development and external validation of a clinical prognostic score for death in visceral leishmaniasis patients in a high HIV co-infection burden area in Ethiopia. Plos One. 12: e0178996. PMID 28582440 DOI: 10.1371/Journal.Pone.0178996  0.414
2017 Assefa Y, Gilks CF, Lynen L, Williams O, Hill PS, Tolera T, Malvia A, Van Damme W. Performance of the Antiretroviral Treatment Program in Ethiopia, 2005-2015: strengths and weaknesses toward ending AIDS. International Journal of Infectious Diseases : Ijid : Official Publication of the International Society For Infectious Diseases. PMID 28533167 DOI: 10.1016/J.Ijid.2017.05.012  0.316
2017 Abongomera C, Ritmeijer K, Vogt F, Buyze J, Mekonnen Z, Admassu H, Colebunders R, Mohammed R, Lynen L, Diro E, Griensven Jv. Development and external validation of a clinical prognostic score for death in visceral leishmaniasis patients in an area of Ethiopia with a high burden of HIV co-infection F1000research. 6. DOI: 10.7490/F1000Research.1114083.1  0.437
2016 van Griensven J, Bah EI, Haba N, Delamou A, Camara BS, Olivier KJ, De Clerck H, Nordenstedt H, Semple MG, Van Herp M, Buyze J, De Crop M, Van Den Broucke S, Lynen L, De Weggheleire A, et al. Electrolyte and Metabolic Disturbances in Ebola Patients during a Clinical Trial, Guinea, 2015. Emerging Infectious Diseases. 22. PMID 27869610 DOI: 10.3201/Eid2212.161136  0.308
2016 Diro E, Yansouni C, Takele Y, Mengesha B, Lynen L, Hailu A, van Griensven J, Boelaert M, Büscher P. Diagnosis of Visceral Leishmaniasis Using Peripheral Blood Microscopy in Ethiopia: A Prospective Phase-III Study of the Diagnostic Performance of Different Concentration Techniques Compared to Tissue Aspiration. The American Journal of Tropical Medicine and Hygiene. PMID 27799651 DOI: 10.4269/Ajtmh.16-0362  0.321
2016 Stek C, Schutz C, Blumenthal L, Thienemann F, Buyze J, Nöstlinger C, Ravinetto R, Wouters E, Colebunders R, Maartens G, Wilkinson RJ, Lynen L, Meintjes G. Preventing Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome in High-Risk Patients: Protocol of a Randomized Placebo-Controlled Trial of Prednisone (PredART Trial). Jmir Research Protocols. 5: e173. PMID 27571786 DOI: 10.2196/Resprot.6046  0.4
2016 Iroezindu MO, Ofondu EO, Mbata GC, van Wyk B, Hausler HP, Dh A, Lynen L, Hopewell PC. Factors Associated with Prevalent Tuberculosis Among Patients Receiving Highly Active Antiretroviral Therapy in a Nigerian Tertiary Hospital. Annals of Medical and Health Sciences Research. 6: 120-8. PMID 27213096 DOI: 10.4103/2141-9248.181837  0.388
2016 Daneau G, Buyze J, Wade D, Diaw PA, Dieye TN, Thai S, Florence E, Lynen L, Kestens L. CD4 results with a bias larger than hundred cells per microliter can have a significant impact on the clinical decision during treatment initiation of HIV patients. Cytometry. Part B, Clinical Cytometry. PMID 26917223 DOI: 10.1002/Cyto.B.21366  0.312
2016 Edwards T, Semple MG, De Weggheleire A, Claeys Y, De Crop M, Menten J, Ravinetto R, Temmerman S, Lynen L, Bah EI, Smith PG, van Griensven J. Design and analysis considerations in the Ebola_Tx trial evaluating convalescent plasma in the treatment of Ebola virus disease in Guinea during the 2014-2015 outbreak. Clinical Trials (London, England). PMID 26768570 DOI: 10.1177/1740774515621056  0.322
2015 Pe R, Chim B, Thai S, Lynen L, van Griensven J. Advanced HIV Disease at Enrolment in HIV Care: Trends and Associated Factors over a Ten Year Period in Cambodia. Plos One. 10: e0143320. PMID 26606057 DOI: 10.1371/Journal.Pone.0143320  0.454
2015 Diro E, Ritmeijer K, Boelaert M, Alves F, Mohammed R, Abongomera C, Ravinetto R, De Crop M, Fikre H, Adera C, Colebunders R, van Loen H, Menten J, Lynen L, Hailu A, et al. Use of Pentamidine As Secondary Prophylaxis to Prevent Visceral Leishmaniasis Relapse in HIV Infected Patients, the First Twelve Months of a Prospective Cohort Study. Plos Neglected Tropical Diseases. 9: e0004087. PMID 26431253 DOI: 10.1371/Journal.Pntd.0004087  0.476
2015 van Griensven J, Choun K, Chim B, Thai S, Lorent N, Lynen L. Implementation of isoniazid preventive therapy in an HIV clinic in Cambodia: high rates of discontinuation when combined with antiretroviral therapy. Tropical Medicine & International Health : Tm & Ih. 20: 1823-31. PMID 26426387 DOI: 10.1111/Tmi.12609  0.488
2015 Diro E, Lynen L, Assefa M, Takele Y, Mengesha B, Adem E, Mohammed R, Kimutai R, Hailu A, Boelaert M, van Griensven J. Impact of the use of a rapid diagnostic test for visceral leishmaniasis on clinical practice in Ethiopia: a retrospective study. Plos Neglected Tropical Diseases. 9: e0003738. PMID 25965564 DOI: 10.1371/Journal.Pntd.0003738  0.385
2015 Diro E, Lynen L, Gebregziabiher B, Assefa A, Lakew W, Belew Z, Hailu A, Boelaert M, van Griensven J. Clinical aspects of paediatric visceral leishmaniasis in North-west Ethiopia. Tropical Medicine & International Health : Tm & Ih. 20: 8-16. PMID 25329449 DOI: 10.1111/Tmi.12407  0.408
2015 Diro E, van Griensven J, Mohammed R, Colebunders R, Asefa M, Hailu A, Lynen L. Atypical manifestations of visceral leishmaniasis in patients with HIV in north Ethiopia: a gap in guidelines for the management of opportunistic infections in resource poor settings. The Lancet. Infectious Diseases. 15: 122-9. PMID 25300862 DOI: 10.1016/S1473-3099(14)70833-3  0.46
2014 Kenyon C, Lynen L, Florence E, Caluwaerts S, Vandenbruaene M, Apers L, Soentjens P, Van Esbroeck M, Bottieau E. Syphilis reinfections pose problems for syphilis diagnosis in Antwerp, Belgium - 1992 to 2012. Euro Surveillance : Bulletin EuropéEn Sur Les Maladies Transmissibles = European Communicable Disease Bulletin. 19: 20958. PMID 25411690 DOI: 10.2807/1560-7917.Es2014.19.45.20958  0.397
2014 Labhardt ND, Cheleboi M, Faturyiele O, Motlatsi MM, Pfeiffer K, Lejone TI, Cerutti B, Muser J, Gupta RS, Lynen L, Hatz C. Higher rates of metabolic syndrome among women taking zidovudine as compared to tenofovir in rural Africa: preliminary data from the CART-1 study. Journal of the International Aids Society. 17: 19552. PMID 25394059 DOI: 10.7448/Ias.17.4.19552  0.302
2014 van Griensven J, Diro E, Lopez-Velez R, Ritmeijer K, Boelaert M, Zijlstra EE, Hailu A, Lynen L. A screen-and-treat strategy targeting visceral leishmaniasis in HIV-infected individuals in endemic East African countries: the way forward? Plos Neglected Tropical Diseases. 8: e3011. PMID 25101627 DOI: 10.1371/Journal.Pntd.0003011  0.478
2014 van Griensven J, Ritmeijer K, Lynen L, Diro E. Visceral leishmaniasis as an AIDS defining condition: towards consistency across WHO guidelines. Plos Neglected Tropical Diseases. 8: e2916. PMID 25032826 DOI: 10.1371/Journal.Pntd.0002916  0.482
2014 Diro E, Lynen L, Ritmeijer K, Boelaert M, Hailu A, van Griensven J. Visceral Leishmaniasis and HIV coinfection in East Africa. Plos Neglected Tropical Diseases. 8: e2869. PMID 24968313 DOI: 10.1371/Journal.Pntd.0002869  0.47
2014 Diro E, Lynen L, Mohammed R, Boelaert M, Hailu A, van Griensven J. High parasitological failure rate of visceral leishmaniasis to sodium stibogluconate among HIV co-infected adults in Ethiopia. Plos Neglected Tropical Diseases. 8: e2875. PMID 24854196 DOI: 10.1371/Journal.Pntd.0002875  0.488
2014 Lorent N, Choun K, Thai S, Kim T, Huy S, Pe R, van Griensven J, Buyze J, Colebunders R, Rigouts L, Lynen L. Community-based active tuberculosis case finding in poor urban settlements of Phnom Penh, Cambodia: a feasible and effective strategy. Plos One. 9: e92754. PMID 24675985 DOI: 10.1371/Journal.Pone.0092754  0.401
2014 van Griensven J, Phirum L, Choun K, Thai S, De Weggheleire A, Lynen L. Hepatitis B and C co-infection among HIV-infected adults while on antiretroviral treatment: long-term survival, CD4 cell count recovery and antiretroviral toxicity in Cambodia. Plos One. 9: e88552. PMID 24533106 DOI: 10.1371/Journal.Pone.0088552  0.32
2014 van Griensven J, Phan V, Thai S, Koole O, Lynen L. Simplified clinical prediction scores to target viral load testing in adults with suspected first line treatment failure in Phnom Penh, Cambodia. Plos One. 9: e87879. PMID 24504463 DOI: 10.1371/Journal.Pone.0087879  0.356
2014 Van Griensven J, Carrillo E, López-Vélez R, Lynen L, Moreno J. Leishmaniasis in immunosuppressed individuals Clinical Microbiology and Infection. 20: 286-299. PMID 24450618 DOI: 10.1111/1469-0691.12556  0.459
2014 van Griensven J, Phirum L, Thai S, Buyze J, Lynen L. A clinical prediction score for targeted creatinine testing before initiating tenofovir-based antiretroviral treatment in Cambodia. Journal of Acquired Immune Deficiency Syndromes (1999). 65: e150-2. PMID 24121759 DOI: 10.1097/Qai.0000000000000022  0.311
2013 Phe T, Thai S, Veng C, Sok S, Lynen L, van Griensven J. Risk factors of treatment-limiting anemia after substitution of zidovudine for stavudine in HIV-infected adult patients on antiretroviral treatment. Plos One. 8: e60206. PMID 23555926 DOI: 10.1371/Journal.Pone.0060206  0.408
2013 Choun K, Pe R, Thai S, Lorent N, Lynen L, van Griensven J. Timing of antiretroviral therapy in Cambodian hospital after diagnosis of tuberculosis: impact of revised WHO guidelines. Bulletin of the World Health Organization. 91: 195-206. PMID 23476092 DOI: 10.2471/Blt.12.111153  0.453
2013 van Griensven J, Diro E, Lopez-Velez R, Boelaert M, Lynen L, Zijlstra E, Dujardin JC, Hailu A. HIV-1 protease inhibitors for treatment of visceral leishmaniasis in HIV-co-infected individuals. The Lancet. Infectious Diseases. 13: 251-9. PMID 23427890 DOI: 10.1016/S1473-3099(12)70348-1  0.464
2013 Phan V, Thai S, Koole O, Menten J, Meheus F, van Griensven J, Lynen L. Validation of a clinical prediction score to target viral load testing in adults with suspected first-line treatment failure in resource-constrained settings. Journal of Acquired Immune Deficiency Syndromes (1999). 62: 509-16. PMID 23334504 DOI: 10.1097/Qai.0B013E318285D28C  0.343
2013 Choun K, Thai S, Pe R, Lorent N, Lynen L, van Griensven J. Incidence and risk factors for tuberculosis in HIV-infected patients while on antiretroviral treatment in Cambodia. Transactions of the Royal Society of Tropical Medicine and Hygiene. 107: 235-42. PMID 23324313 DOI: 10.1093/Trstmh/Trt001  0.427
2013 Chim B, Piseth SS, Heng VC, Sopheak T, Lynen L, Van Griensven J. Integrated cryptococcal antigen screening and pre-emptive treatment prior to initiation of antiretroviral treatment in Cambodia Journal of Aids and Clinical Research. 4. DOI: 10.4172/2155-6113.1000227  0.372
2012 Mehta M, Semitala F, Lynen L, Colebunders R. Antiretroviral treatment in low-resource settings: what has changed in the last 10 years and what needs to change in the coming years? Expert Review of Anti-Infective Therapy. 10: 1287-96. PMID 23241186 DOI: 10.1586/Eri.12.129  0.43
2012 Lynen L, Fransen K, Van Griensven J, Colebunders R. Pretreatment HIV-1 drug resistance testing in sub-Saharan Africa. The Lancet. Infectious Diseases. 12: 911. PMID 23174380 DOI: 10.1016/S1473-3099(12)70279-7  0.382
2012 Labhardt ND, Lejone T, Setoko M, Poka M, Ehmer J, Pfeiffer K, Kiuvu PZ, Lynen L. A clinical prediction score in addition to WHO criteria for anti-retroviral treatment failure in resource-limited settings--experience from Lesotho. Plos One. 7: e47937. PMID 23118910 DOI: 10.1371/Journal.Pone.0047937  0.335
2012 McCarthy KD, Cain KP, Winthrop KL, Udomsantisuk N, Lan NT, Sar B, Kimerling ME, Kanara N, Lynen L, Monkongdee P, Tasaneeyapan T, Varma JK. Nontuberculous mycobacterial disease in patients with HIV in Southeast Asia. American Journal of Respiratory and Critical Care Medicine. 185: 981-8. PMID 22345581 DOI: 10.1164/rccm.201107-1327OC  0.35
2012 Phan V, Thai S, Choun K, Lynen L, van Griensven J. Incidence of treatment-limiting toxicity with stavudine-based antiretroviral therapy in Cambodia: a retrospective cohort study. Plos One. 7: e30647. PMID 22303447 DOI: 10.1371/Journal.Pone.0030647  0.358
2012 Mukabatsinda C, Nguyen J, Bisig B, Lynen L, Coppens YD, Asiimwe A, Van den Ende J. Is increasing complexity of algorithms the price for higher accuracy? virtual comparison of three algorithms for tertiary level management of chronic cough in people living with HIV in a low-income country. Bmc Medical Informatics and Decision Making. 12: 2. PMID 22260242 DOI: 10.1186/1472-6947-12-2  0.323
2012 Vlieghe E, Phe T, Hallin M, Denis O, Deplano A, Smet BD, Veng C, Kham C, Lynen L, Peetermans W, Jacobs J. Staphylococcus aureus blood stream infections in Cambodian adults International Journal of Infectious Diseases. 16. DOI: 10.1016/J.Ijid.2012.05.616  0.338
2011 Schouten EJ, Jahn A, Midiani D, Makombe SD, Mnthambala A, Chirwa Z, Harries AD, van Oosterhout JJ, Meguid T, Ben-Smith A, Zachariah R, Lynen L, Zolfo M, Van Damme W, Gilks CF, et al. Prevention of mother-to-child transmission of HIV and the health-related Millennium Development Goals: time for a public health approach. Lancet. 378: 282-4. PMID 21763940 DOI: 10.1016/S0140-6736(10)62303-3  0.416
2011 De Weggheleire A, Bortolotti V, Zolfo M, Crowley S, Colebunders R, Riedner G, Lynen L. Challenges in developing national HIV guidelines: experience from the eastern Mediterranean. Bulletin of the World Health Organization. 89: 442-50. PMID 21673860 DOI: 10.2471/Blt.10.083790  0.447
2011 Abouyannis M, Menten J, Kiragga A, Lynen L, Robertson G, Castelnuovo B, Manabe YC, Reynolds SJ, Roberts L. Development and validation of systems for rational use of viral load testing in adults receiving first-line ART in sub-Saharan Africa. Aids (London, England). 25: 1627-35. PMID 21673555 DOI: 10.1097/Qad.0B013E328349A414  0.315
2011 Koole O, Thai S, Khun KE, Pe R, van Griensven J, Apers L, Van den Ende J, Mao TE, Lynen L. Evaluation of the 2007 WHO guideline to improve the diagnosis of tuberculosis in ambulatory HIV-positive adults. Plos One. 6: e18502. PMID 21494694 DOI: 10.1371/Journal.Pone.0018502  0.444
2011 Zolfo M, Bateganya MH, Adetifa IM, Colebunders R, Lynen L. A telemedicine service for HIV/AIDS physicians working in developing countries. Journal of Telemedicine and Telecare. 17: 65-70. PMID 21078680 DOI: 10.1258/Jtt.2010.100308  0.313
2011 Zolfo M, Schapiro JM, Phan V, Koole O, Thai S, Vekemans M, Fransen K, Lynen L. Genotypic impact of prolonged detectable HIV type 1 RNA viral load after HAART failure in a CRF01_AE-infected cohort. Aids Research and Human Retroviruses. 27: 727-35. PMID 20854169 DOI: 10.1089/Aid.2010.0037  0.436
2010 Gheuens E, Colson AW, Florence E, Augustijn H, Verpooten GA, Lynen L. Prevalence of chronic renal failure stage 3 or more in HIV-infected patients in Antwerp: An observational study Acta Clinica Belgica. 65: 392-398. PMID 21268952 DOI: 10.1186/1758-2652-13-S4-P89  0.423
2010 Conesa-Botella A, Florence E, Lynen L, Colebunders R, Menten J, Moreno-Reyes R. Decrease of vitamin D concentration in patients with HIV infection on a non nucleoside reverse transcriptase inhibitor-containing regimen. Aids Research and Therapy. 7: 40. PMID 21092280 DOI: 10.1186/1742-6405-7-40  0.344
2010 Zolfo M, Iglesias D, Kiyan C, Echevarria J, Fucay L, Llacsahuanga E, de Waard I, Suàrez V, Llaque WC, Lynen L. Mobile learning for HIV/AIDS healthcare worker training in resource-limited settings. Aids Research and Therapy. 7: 35. PMID 20825677 DOI: 10.1186/1742-6405-7-35  0.354
2010 van Griensven J, Sopheak T, Aseffa Y, Van Damme W, Lynen L. Attrition of HIV-infected individuals not yet eligible for antiretroviral treatment: do we care? Transactions of the Royal Society of Tropical Medicine and Hygiene. 104: 690-2; author reply . PMID 20800253 DOI: 10.1016/J.Trstmh.2010.07.006  0.435
2010 Ejara ED, Lynen L, Boelaert M, Van Griensven J. Challenges in HIV and visceral Leishmania co-infection: future research directions. Tropical Medicine & International Health : Tm & Ih. 15: 1266-7. PMID 20723183 DOI: 10.1111/J.1365-3156.2010.02612.X  0.404
2010 Zolfo M, De Weggheleire A, Schouten E, Lynen L. Time for "test and treat" in prevention of mother-to-child transmission programs in low- and middle-income countries. Journal of Acquired Immune Deficiency Syndromes (1999). 55: 287-9. PMID 20714271 DOI: 10.1097/Qai.0B013E3181Eef3Da  0.427
2010 van Griensven J, Balasegaram M, Meheus F, Alvar J, Lynen L, Boelaert M. Combination therapy for visceral leishmaniasis. The Lancet. Infectious Diseases. 10: 184-94. PMID 20185097 DOI: 10.1016/S1473-3099(10)70011-6  0.368
2010 Buvé A, Lynen L. Treating HIV infection with drugs for HSV-2 infection? Lancet (London, England). 375: 782-4. PMID 20153889 DOI: 10.1016/S0140-6736(10)60097-9  0.396
2010 Lynen L, Van Griensven J, Elliott J. Monitoring for treatment failure in patients on first-line antiretroviral treatment in resource-constrained settings. Current Opinion in Hiv and Aids. 5: 1-5. PMID 20046141 DOI: 10.1097/Coh.0B013E3283333762  0.409
2010 Buvé A, Lynen L. Treatment of HIV infection with drugs for HSV-2 infection - Authors' reply The Lancet. 376: 88. DOI: 10.1016/S0140-6736(10)61070-7  0.473
2010 Buvé A, Lynen L. Treatment of HIV infection with drugs for HSV-2 infection – Authors' reply The Lancet. 376: 88. DOI: 10.1016/S0140-6736(10)61070-7  0.303
2009 Thai S, Koole O, Un P, Ros S, De Munter P, Van Damme W, Jacques G, Colebunders R, Lynen L. Five-year experience with scaling-up access to antiretroviral treatment in an HIV care programme in Cambodia Tropical Medicine and International Health. 14: 1048-1058. PMID 19573140 DOI: 10.1111/J.1365-3156.2009.02334.X  0.406
2009 Lynen L, An S, Koole O, Thai S, Ros S, De Munter P, Sculier D, Arnould L, Fransen K, Menten J, Boelaert M, Van den Ende J, Colebunders R. An algorithm to optimize viral load testing in HIV-positive patients with suspected first-line antiretroviral therapy failure in Cambodia. Journal of Acquired Immune Deficiency Syndromes (1999). 52: 40-8. PMID 19550349 DOI: 10.1097/Qai.0B013E3181Af6705  0.366
2008 Bottieau E, Florence E, Clerinx J, Vlieghe E, Vekemans M, Moerman F, Lynen L, Colebunders R, Van Gompel A, Van den Ende J. Fever after a stay in the tropics: clinical spectrum and outcome in HIV-infected travelers and migrants. Journal of Acquired Immune Deficiency Syndromes (1999). 48: 547-52. PMID 18645519 DOI: 10.1097/Qai.0B013E31817Bebc5  0.328
2008 Bottieau E, Florence E, De Boer M, Vlieghe E, Demeester R, Vekemans M, Moerman F, Lynen L, Francque S, Michielsen P. Treatment outcome of chronic hepatitis C in HIV-infected patients at the Institute of Tropical Medicine, Antwerp, Belgium, from 2000 to 2008 Journal of the International Aids Society. 11: P283. DOI: 10.1186/1758-2652-11-S1-P283  0.313
2007 Huyst V, Lynen L, Bottieau E, Zolfo M, Kestens L, Colebunders R. Immune reconstitution inflammatory syndrome in an HIV/TB co-infected patient four years after starting antiretroviral therapy Acta Clinica Belgica. 62: 126-129. PMID 17547295 DOI: 10.1179/Acb.2007.022  0.45
2007 Kong BN, Harwell JI, Suos P, Lynen L, Mohiuddin S, Reinert S, Pugatch D. Opportunistic infections and HIV clinical disease stage among patients presenting for care in Phnom Penh, Cambodia. The Southeast Asian Journal of Tropical Medicine and Public Health. 38: 62-8. PMID 17539248  0.372
2007 Lynen L, Phan S, Prey SP, Sopheak T, Harwell J, Boelaert M, Koole O, Colebunders R. Does Hyponatremia have a Value in the Diagnosis of Extrapulmonary Tuberculosis in HIV-1 Infected Patients in Cambodia? The Open Infectious Diseases Journal. 1: 1-3. DOI: 10.2174/1874279300701010001  0.367
2006 Colebunders R, John L, Huyst V, Kambugu A, Scano F, Lynen L. Tuberculosis immune reconstitution inflammatory syndrome in countries with limited resources International Journal of Tuberculosis and Lung Disease. 10: 946-953. PMID 16964782  0.373
2006 Sok P, Harwell JI, McGarvey ST, Lurie M, Lynen L, Flanigan T, Mayer KH. Demographic and clinical characteristics of HIV-infected inpatients and outpatients at a Cambodian hospital. Aids Patient Care and Stds. 20: 369-78. PMID 16706711 DOI: 10.1089/Apc.2006.20.369  0.326
2006 Lynen L, Thai S, De Munter P, Leang B, Sokkab A, Schrooten W, Huyst V, Kestens L, Jacques G, Colebunders R, Menten J, Van Den Ende J. The added value of a CD4 count to identify patients eligible for highly active antiretroviral therapy among HIV-positive adults in Cambodia Journal of Acquired Immune Deficiency Syndromes. 42: 322-324. PMID 16688095 DOI: 10.1097/01.Qai.0000221682.37316.D5  0.313
2006 Zolfo M, Lynen L, Dierckx J, Colebunders R. Remote consultations and HIV/AIDS continuing education in low-resource settings International Journal of Medical Informatics. 75: 633-637. PMID 16647877 DOI: 10.1016/J.Ijmedinf.2006.03.002  0.413
2006 Colebunders R, Moses KR, Laurence J, Shihab HM, Semitala F, Lutwama F, Bakeera-Kitaka S, Lynen L, Spacek L, Reynolds SJ, Quinn TC, Viner B, Mayanja-Kizza H. A new model to monitor the virological efficacy of antiretroviral treatment in resource-poor countries. The Lancet. Infectious Diseases. 6: 53-9. PMID 16377535 DOI: 10.1016/S1473-3099(05)70327-3  0.308
2006 Bateganya M, Muhwezi J, Mugyenyi P, Kityo C, Lynen L, Zolfo M, Colebunders R. Persistent galactorrhea in a postmenopausal woman with herpes zoster and HIV-1 infection - case report Malawi Medical Journal. 17: 100-101. DOI: 10.4314/Mmj.V17I3.10890  0.416
2005 Bun Navy K, Prem Prey S, Lynen L, Sovanna P, Bell JD, Harwell JI. The first reported cases of disseminated histoplasmosis in Cambodia, complicated by multiple opportunistic infections Southeast Asian Journal of Tropical Medicine and Public Health. 36: 1272-1274. PMID 16438157  0.309
2005 Apers L, Lynen L, Worodria W, Colebunders R. Review editorial: prevention of tuberculosis in resource-poor countries with increasing access to highly active antiretroviral treatment. Tropical Medicine & International Health : Tm & Ih. 10: 1209-14. PMID 16359399 DOI: 10.1111/J.1365-3156.2005.01516.X  0.374
2005 Colebunders R, Zolfo M, Lynen L. Severe dyshidrosis in two patients with HIV infection shortly after starting highly active antiretroviral treatment Dermatology Online Journal. 11. PMID 16150239  0.364
2005 Colebunders R, John L, Muganzi A, Lynen L, Kambugu A. Palliative care in sub-Saharan Africa [4] Lancet. 366: 546-547. PMID 16099287 DOI: 10.1016/S0140-6736(05)67094-8  0.391
2004 Leang B, Lynen L, Lim K, Jacques G, Van Esbroeck M, Zolfo M. Disseminated nocardiosis presenting with cardiac tamponade in an HIV patient. International Journal of Std & Aids. 15: 839-40. PMID 15601492 DOI: 10.1258/0956462042563620  0.315
2003 Colebunders R, Florence E, Lynen L, Bouckenooghe A. Highly active antiretroviral treatment in countries with very limited resources: Do we have cheaper alternatives? International Journal of Std and Aids. 14: 1-5. PMID 12590784 DOI: 10.1258/095646203321043174  0.42
2002 Florence E, Bottieau E, Lynen L, Colebunders R. Patients with HIV infection and fever: A diagnostic approach Acta Clinica Belgica. 57: 184-190. PMID 12462794 DOI: 10.1179/Acb.2002.040  0.411
2001 Van Den Ende J, Morales I, Van Den Abbeele K, Clerinx J, Colebunders R, Kager P, Lynen L, Van Gompel A, Van Der Planken M, Vervoort T. Changing epidemiological and clinical aspects of imported malaria in Belgium Journal of Travel Medicine. 8: 19-25. PMID 11182605 DOI: 10.2310/7060.2001.5147  0.334
1998 Van Den Ende J, Lynen L, Elsen P, Colebunders R, Demey H, Depraetere K, De Schrijver K, Peetermans WE, Pereira De Almeida P, Vogelaers D. A cluster of airport malaria in Belgium in 1995 Acta Clinica Belgica. 53: 259-263. PMID 9795446 DOI: 10.1080/17843286.1998.11772033  0.303
Show low-probability matches.